When Japan's revised Cannabis Control Act came into force on December 12, 2024, it introduced product-specific Δ9-THC residue limits for the first time. Most international brands are aware of the headline figure — 10 ppm for oils and powders. Far fewer are aware that this limit does not apply to all product types, and that the limit for water-soluble products is one hundred times stricter.
The Three-Tier Residue Standard
| Product Category | Δ9-THC Limit | Expression | Notes |
|---|---|---|---|
| Oils & Powders | ≤ 10 ppm | 10 mg/kg | Standard CBD oils, tinctures, capsules in oil base |
| Aqueous / Water-Soluble | ≤ 0.1 ppm | 0.10 mg/kg | 100× stricter — most frequently overlooked |
| All Other Forms | ≤ 1 ppm | 1 mg/kg | Gummies, softgels, topicals, most edibles |
Critical: A water-soluble CBD powder that passes the 10 ppm oil standard may exceed Japan's legal limit by a factor of 100. This single oversight has caused multiple failed import attempts by international brands.
What Counts as "Aqueous / Water-Soluble"?
MHLW guidance issued in February 2026 clarified the scope of the 0.1 ppm limit. The following product types fall under the aqueous category regardless of their form factor when sold:
- Water-soluble CBD powders intended for dissolution in beverages
- Emulsified CBD concentrates intended for dilution in water
- Ready-to-drink CBD beverages
- CBD beverage premixes and sachets
- CBD nanotechnology formulations in aqueous base
Products that are oil-based at point of sale but include instructions for water dilution may be subject to interpretation. When in doubt, apply the 0.1 ppm standard or seek a formal assessment.
Why the 0.1 ppm Limit Is So Difficult to Meet
Water-soluble CBD formulations typically use full-spectrum or broad-spectrum extracts because isolate performs poorly in aqueous emulsification. Full-spectrum and broad-spectrum extracts by definition contain residual THC. Achieving 0.1 ppm THC in a finished water-soluble product requires either:
- Starting with a CBD isolate (99%+ purity, essentially zero residual THC), or
- Using a broad-spectrum extract that has been chromatographically purified to non-detect THC levels, verified by a Japan-accredited lab
Standard "THC-free" broad-spectrum extracts often contain THC at levels of 1–5 ppm — well within the oil standard, but 10–50× above the aqueous limit.
The Japanese Lab Requirement
Overseas CoA documentation is not accepted for Japanese import notification regardless of the testing laboratory's international accreditation. All THC residue testing must be performed by a laboratory certified under Japan's Pharmaceutical and Medical Device Act testing standards. There are currently fewer than twenty such laboratories in Japan with cannabinoid testing capability.
Practical note: Coordinating testing through a Japan-accredited laboratory from outside Japan requires lead time of 3–6 weeks minimum. Plan this into your market entry timeline.
Common Mistakes and How to Avoid Them
Mistake 1: Applying the oil standard universally
Many international brands read "10 ppm" as Japan's CBD THC limit and assume it applies to all products. Before filing any import documentation, confirm which of the three tiers applies to your specific product format.
Mistake 2: Using overseas CoA data for Japanese filings
Even if your product tests at 0.05 ppm THC at a US or EU laboratory, this result cannot be used for MHLW import notification. Japanese-certified testing is mandatory.
Mistake 3: Not accounting for THC degradation during shipping
CBD can degrade to THC under heat and UV exposure during transit. Products that test below the limit at origin may exceed it on arrival. Testing should ideally be conducted close to shipment time, and packaging should minimize degradation risk.